Association of ACE2 and TMPRSS2 Genes Variants with Disease Severity and Most Important Biomarkers in COVID-19 Patients in Bosnia and Herzegovina

Overview

Journal Croat Med J

Specialty General Medicine

Date 2024 Jun 13

PMID 38868968

Authors

Neven Meseldzic

Besim Prnjavorac

Tanja Dujic

Maja Malenica

Una Glamoclija

Lejla Prnjavorac

Omer Bedak

Selma Imamovic Kadric

Damir Marjanovic

Tamer Bego

Affiliations

Soon will be listed here.

Abstract

Aim: To assess the association of single nucleotide polymorphisms (SNPs) in the ACE2 and TMPRSS2 genes with COVID-19 severity and key biomarkers.

Methods: The study involved 750 COVID-19 patients from Bosnia and Herzegovina, divided into three groups: mild, moderate, and severe cases. Genetic variations within the ACE2 (rs2285666) and TMPRSS2 (rs2070788) genes were examined with real-time polymerase chain reaction. Biochemical markers were determined with standard procedures.

Results: There was a significant difference in the rs2070788 genotype distribution between patients with mild and moderate symptoms, but not between other groups. For the rs2285666 polymorphism, no significant difference in genotype distribution was found. In patients with mild symptoms, carriers of the GG genotype of rs2070788 had significantly higher total bilirubin levels than carriers of the AA genotype. Similarly, carriers of the TT genotype of rs2285666 had significantly higher activated partial thromboplastin time and international normalized ratio, and lower lactate dehydrogenase levels compared with the CC genotype. Among patients with severe symptoms, carriers of the GG genotype showed significantly higher potassium levels than carriers of the AA genotype, while carriers of the TT genotype showed significantly higher erythrocyte count as well as hemoglobin and hematocrit levels compared with the CC genotype.

Conclusion: This study highlights the role of genetic factors, particularly SNPs in the ACE2 and TMPRSS2 genes, in determining COVID-19 severity, aiding patient risk assessment and prognosis.

Citing Articles

Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics.

Garrido N, Gonzalez-Martinez F, Torres A, Blasco-Segura P, Losada S, Plaza A Int J Mol Sci. 2025; 26(2).

PMID: 39859435 PMC: 11765594. DOI: 10.3390/ijms26020722.

References

Palladino M . Complete blood count alterations in COVID-19 patients: A narrative review. Biochem Med (Zagreb). 2021; 31(3):030501. PMC: 8495616. DOI: 10.11613/BM.2021.030501. View

Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

Noori M, Nejadghaderi S, Sullman M, Carson-Chahhoud K, Ardalan M, Kolahi A . How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels?. Mol Biol Rep. 2021; 48(9):6655-6661. PMC: 8364628. DOI: 10.1007/s11033-021-06642-0. View

Khalilzadeh F, Sakhaee F, Sotoodehnejadnematalahi F, Zamani M, Ahmadi I, Anvari E . Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population. Int J Immunogenet. 2022; 49(5):325-332. PMC: 9539076. DOI: 10.1111/iji.12598. View

Li J, Wang Y, Liu Y, Zhang Z, Zhai Y, Dai Y . Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review. Eur J Med Res. 2022; 27(1):26. PMC: 8861605. DOI: 10.1186/s40001-022-00647-6. View

Schonfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F . Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study. Front Genet. 2021; 12:667231. PMC: 8097083. DOI: 10.3389/fgene.2021.667231. View

Jackson C, Farzan M, Chen B, Choe H . Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2021; 23(1):3-20. PMC: 8491763. DOI: 10.1038/s41580-021-00418-x. View

Salihefendic L, Ceko I, Besic L, Mulahuseinovic N, Durgut S, Pecar D . Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. Front Genet. 2023; 14:1240245. PMC: 10545899. DOI: 10.3389/fgene.2023.1240245. View

Strope J, PharmD C, Figg W . TMPRSS2: Potential Biomarker for COVID-19 Outcomes. J Clin Pharmacol. 2020; 60(7):801-807. PMC: 7280622. DOI: 10.1002/jcph.1641. View

10.

Akin S, Schriek P, Van Nieuwkoop C, Neuman R, Meynaar I, van Helden E . A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity. J Hypertens. 2021; 40(3):606-614. PMC: 8815849. DOI: 10.1097/HJH.0000000000003054. View

11.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

12.

Limburg H, Harbig A, Bestle D, Stein D, Moulton H, Jaeger J . TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes. J Virol. 2019; 93(21). PMC: 6803253. DOI: 10.1128/JVI.00649-19. View

13.

Aziz M, Islam M . Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID-19: A meta-analysis. Mol Genet Genomic Med. 2022; 10(11):e2063. PMC: 9538166. DOI: 10.1002/mgg3.2063. View

14.

Pandey R, Srivastava A, Singh P, Chaubey G . Genetic association of TMPRSS2 rs2070788 polymorphism with COVID-19 case fatality rate among Indian populations. Infect Genet Evol. 2022; 98:105206. PMC: 8730738. DOI: 10.1016/j.meegid.2022.105206. View

15.

Horowitz J, Kosmicki J, Damask A, Sharma D, Roberts G, Justice A . Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat Genet. 2022; 54(4):382-392. PMC: 9005345. DOI: 10.1038/s41588-021-01006-7. View

16.

Ozturk R, Tasova Y, Ayaz A . COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings. Turk J Med Sci. 2020; 50(SI-1):638-657. DOI: 10.3906/sag-2005-287. View

17.

Hu X, Ma Y, Lin Y, Wu X, Wu J, Ma H . ACE2 and TMPRSS2 Expression in Hepatocytes of Chronic HBV Infection Patients. Infect Dis Immun. 2024; 1(1):36-42. PMC: 8057318. DOI: 10.1097/ID9.0000000000000007. View

18.

Traets M, Nijhuis R, Morre S, Ouburg S, Remijn J, Blok B . Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19. PLoS One. 2022; 17(1):e0260897. PMC: 8740962. DOI: 10.1371/journal.pone.0260897. View

19.

Singh H, Choudhari R, Nema V, Khan A . ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microb Pathog. 2020; 150:104621. PMC: 7709597. DOI: 10.1016/j.micpath.2020.104621. View

20.

Abdelsattar S, Kasemy Z, Ewida S, Abo-Elsoud R, Zytoon A, Abdelaal G . and SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection. Br J Biomed Sci. 2022; 79:10238. PMC: 8915702. DOI: 10.3389/bjbs.2021.10238. View